Skip to content

Digital health to support physical activity in lung transplant candidates

Enhancing physical activity and quality of life in lung transplant candidates through digital health: a feasibility study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15628295
Enrollment
45
Registered
2026-04-09
Start date
2026-04-09
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung transplant Respiratory

Interventions

Arm 1: Digital Physical Activity Intervention + Usual Care Participants assigned to the intervention group will receive a 12-week digital behaviour change intervention alongside their usual care. This
2) an interactive, personalised, web-based dashboard (KiActiv® Health), displaying multiple dimensions of physical activity data with integrated behaviour change tools
3) one-to-one support from a dedicated mentor (6 x 20-minute sessions). After the 12-week intervention, patients will retain access to the dashboard and activity monitor for continued self-management

Sponsors

Northumbria University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Candidates on the waiting list for lung transplant (LTx) with any underlying disease diagnosis 2. Aged 18 years or above

Exclusion criteria

Exclusion criteria: 1. Unable to speak or read English 2. No home internet 3. Presence of any other significant disease or disorder which, in the opinion of the researcher may affect the participant’s ability to participate in the study

Design outcomes

Primary

MeasureTime frame
Feasibility will be assessed through: 1. Recruitment: number of participants approached, screened, screen-failed, consented, as well as reasons for declining participation, measured using a screening log throughout the study 2. Retention: proportion of consented participants completing the study, measured using a study completion log at the end of the study 3. Acceptability: participants' perceptions and experiences of the intervention and study procedures, assessed via qualitative interviews at 24 weeks 4. Adherence: uploading of physical activity data and completeness of patient-reported outcomes, assessed via the digital platform at 0, 12, and 24 weeks 5. Usage of intervention components assessed via the digital platform during the intervention phase (0 to 12 weeks) and follow-up phase (12 to 24 weeks)

Secondary

MeasureTime frame
1. The amount, duration and intensity of physical activity undertaken will be assessed through device-based activity monitoring continuously over 24 weeks Outcomes assessed at baseline (0 weeks), post-intervention (12 weeks) and follow-up (24 weeks): 2. Health-related quality of life (HRQoL) measured using EQ-5D-5L questionnaire 3. Anxiety and depression measured using the Hospital Anxiety and Depression Scale (HADS) 4. Self-efficacy measured using the Self-Efficacy for Managing Chronic Disease Scale 5. Dyspnoea measured using the Dyspnoea-12 questionnaire 6. Fatigue measured using the Functional Assessment of Chronic Illness Therapy Fatigue Scale (FACIT) 7. Mental well-being measured using the Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS) 8. Adverse events measured using adverse event log

Countries

England, United Kingdom

Contacts

Public ContactNathan Skidmore
nathan.skidmore@northumbria.ac.uk-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 23, 2026